C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 235/42 (2006.01) A61K 31/166 (2006.01) A61K 31/4412 (2006.01) A61P 3/10 (2006.01) C07D 213/10 (2006.01)
Patent
CA 2629321
The present invention discloses novel compounds of Formula (I), or pharmaceutically acceptable salts thereof, which have glucagon receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat diabetic and other glucagon related metabolic disorders, and the like.
L'invention porte sur de nouveaux composés de la formule 1 ou des sels pharmaceutiquement acceptables de ces derniers, qui exercent une activité antagoniste ou agoniste inverse sur le récepteur du glucagon, et sur des procédés de préparation desdits composés. Dans un autre mode de réalisation, l'invention concerne des compositions pharmaceutiques renfermant les composés de la formule 1, et des procédés d'utilisation de ces derniers dans le traitement de troubles diabétiques et autres troubles métaboliques liés au glucagon, et analogues.
Chappell Mark Donald
Conner Scott Eugene
Hipskind Philip Arthur
Lamar Jason Eric
Zhu Guoxin
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Glucagon receptor antagonists, preparation and therapeutic uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucagon receptor antagonists, preparation and therapeutic uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucagon receptor antagonists, preparation and therapeutic uses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1944571